Skip to content
★ Sign in to follow
Total declarations
2
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (1 ops.)
€485k

Latest filing published 06 Dec 2007 for HAEMONETICS CORP, €400k.

Insider track record

Disclosed buys
0
Disclosed sells
1
Signal history

No signal scores available.

Thomas Lawlor: trading record in brief

Thomas Lawlor discloses dealings in Haemonetics Corp to SEC (Form 4). The record holds 2 filings, all for trades on 28 November 2007.

Sales make up the whole of the open-market record (1 sale, €485k). Outside the open market, there are 1 option exercise.

Most recently, on 6 December 2007, the filings show an option exercise worth €400k in Haemonetics Corp. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Thomas Lawlor

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations2 total
  • ◇
    President, Patient DivisionExecutivesHaemonetics Corp
    593,875 USD0SEC
    12,500 shares@ US$47.51Common StockSEC:0000313143-07-000065:0
  • ▼
    President, Patient DivisionExecutivesHaemonetics Corp
    719,500 USD0SEC
    12,500 shares@ US$57.56Common StockSEC:0000313143-07-000065:1

2 of 2 declarations